Skip to main content
Log in

Timely and individualized use of immunosuppression is associated with favourable outcomes in paediatric IgA vasculitis nephritis

  • Letter to the Editors
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kurt-Şükür ED, Sekar T, Tullus K (2021) Biopsy-proven Henoch-Schönlein purpura nephritis: a single center experience. Pediatr Nephrol 36:1207–1215. https://doi.org/10.1007/s00467-020-04809-8

    Article  PubMed  Google Scholar 

  2. Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW (2019) European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 58:1607–1616. https://doi.org/10.1093/rheumatology/kez041

    Article  CAS  Google Scholar 

  3. Park JM, Won SC, Shin JI, Yim H, Pai KS (2011) Cyclosporin A therapy for Henoch-Schönlein nephritis with nephrotic-range proteinuria. Pediatr Nephrol 26:411–417. https://doi.org/10.1007/s00467-010-1723-7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eugene Yu-hin Chan.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, M.Hl., Chan, E.Yh. & Ma, A.Lt. Timely and individualized use of immunosuppression is associated with favourable outcomes in paediatric IgA vasculitis nephritis. Pediatr Nephrol 37, 913–914 (2022). https://doi.org/10.1007/s00467-021-05405-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-021-05405-0

Navigation